Patent · US Active

Pyrrolo[2,3-D]pyrimidine compounds

US8372854B2 · kind B2 · utility

3Cited by
0References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 10, 2010
Grant dateFeb 12, 2013
Priority date
Expiry dateFeb 10, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are pyrrolo[2,3-d]pyrimidine compounds, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing these compounds, and methods for their preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.